Search Results - "Forte, Vittorio"
-
1
Thrombin-activatable fibrinolysis inhibitor polymorphisms and recurrent pregnancy loss
Published in Fertility and sterility (01-08-2009)“…Objective To investigate the possible association between selected thrombin-activatable fibrinolysis inhibitor (TAFI) single nucleotide polymorphisms (SNPs)…”
Get full text
Journal Article -
2
Real-life experience of secondary prophylaxis with DOACs in splanchnic venous thrombosis during COVID-19 pandemic
Published in Annals of hematology (01-06-2023)Get full text
Journal Article -
3
Could MicroRNA polymorphisms influence warfarin dosing? A pharmacogenetics study on mir133 genes
Published in Thrombosis research (01-08-2015)“…Abstract MicroRNAs are small single stranded molecules that play a crucial role in regulation of physiological and pathological processes. Recent studies…”
Get full text
Journal Article -
4
Predictors of Early Thrombotic Events in Adult Patients with Acute Myeloid Leukemia: A Real-World Experience
Published in Cancers (17-11-2022)“…Information regarding the incidence and the prognostic impact of thrombotic events (TE) in non-promyelocytic acute myeloid leukemia (AML) is sparse. Although…”
Get full text
Journal Article -
5
Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura
Published in Blood (15-05-2002)Get full text
Journal Article -
6
CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population
Published in Pharmacogenomics (01-02-2009)“…It is known that warfarin treatment is problematic, due to its narrow therapeutic range and to the great interindividual variability. Numerous papers have…”
Get more information
Journal Article -
7
Resequencing of VKORC1 , CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses
Published in Thrombosis research (01-07-2013)“…Abstract Purpose The aim of the present study was to investigate the genetic variability of VKORC1 , CYP2C9 and CYP4F2 genes in patients who required a very…”
Get full text
Journal Article -
8
Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians
Published in Pharmacogenomics (01-11-2007)“…Warfarin is currently considered to be the anticoagulant of choice in the long-term treatment and prevention of thromboembolic events. However, it presents a…”
Get more information
Journal Article -
9
Pattern of Central Nervous System (CNS) Involvement in Adult Acute Myeloid Leukemia (AML) and Its Impact on Outcome
Published in Blood (02-12-2016)“…▪ Background Routine diagnostic lumbar puncture is not recommended in adult patients with acute myeloid leukemia (AML) without Central Nervous System (CNS)…”
Get full text
Journal Article -
10
Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient
Published in Pharmacogenetics and genomics (01-06-2011)“…Warfarin (coumadin) is a worldwide-prescribed anticoagulant for the long-term treatment and prevention of thromboembolic events, presenting a great…”
Get full text
Journal Article -
11
In BCR-ABL1 Positive B-Cell Acute Lymphoblastic Leukemia, Steroid Therapy Induces Hypofibrinogenemia
Published in Journal of clinical medicine (23-03-2022)“…Hypofibrinogenemia (HF) in adult acute lymphoblastic leukemia (ALL) of B lineage is uncommon and mostly associated with asparaginase (ASP) delivery. Since we…”
Get full text
Journal Article -
12
Transient ischemic attack as initial manifestation of acute promyelocytic leukemia
Published in Leukemia research (01-07-2011)Get full text
Journal Article -
13
Multidimensional Flow Cytometry for Detection of Minimal Residual Disease in Acute Myeloid Leukemia
Published in Leukemia & lymphoma (01-01-2003)“…The term minimal residual disease (MRD) describes the situation in which, after chemotherapy for acute leukemia (AL), a morphologically normal bone marrow (BM)…”
Get full text
Journal Article